Frontlight ResearchEarly access
Antiphospholipid syndrome trials in Canada
5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- Where
- Edmonton, Montreal, Rimouski, Sherbrooke
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00 - Phase 1Enrolling by invitationPhase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
- Where
- Sherbrooke
- Age
- 18 years to 85 years
- People
- 144 worldwide
- Run by
- Chugai Pharmaceutical
See details and how to joinNCT06723106 - No phaseTaking peoplePredictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
- Where
- Toronto
- Age
- 18 years to 45 years
- People
- 700 worldwide
- Run by
- Hospital for Special Surgery, New York
See details and how to joinNCT00198068 - Phase 2Taking peopleIMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
- Where
- Toronto
- Age
- 18 years to 40 years
- People
- 55 worldwide
- Run by
- David Ware Branch
See details and how to joinNCT03152058 - No phaseTaking peopleRegistry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS
- Where
- Hamilton
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- McMaster University
See details and how to joinNCT05646394